Tyrosinaemia - Articles and news items

FDA approves higher strength Orfadin capsule for HT-1

Industry news / 15 June 2016 / Victoria White, Digital Content Producer

The FDA has approved a higher strength 20mg capsule of Sobi’s Orfadin (nitisinone) for the treatment of Hereditary Tyrosinaemia type-1 (HT-1)…

 

The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...
+